Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | From the bench to bedside: AML treatment

Charles Craddock • 9 Dec 2017
ASH 2017
General Azacitidine

Understanding the biology of human disease is of the utmost importance to advancing treatment. We are now making excellent headway in the bench-to-bedside translation of knowledge in acute myeloid leukemia (AML), as discussed here by Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, of the University of Birmingham, Birmingham, UK. Speaking from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, Prof. Craddock discusses these breakthroughs.

More from Charles Craddock

Expanding donor access for allogeneic transplantation in AML
2:46
Expanding donor access for allogeneic transplantation in AML
Charles Craddock • 19 Sep 2026
Allogeneic transplantation in fit older adults with AML
1:34
Allogeneic transplantation in fit older adults with AML
Charles Craddock • 19 Sep 2026
Maximizing the graft-versus-leukemia effect after allogeneic transplantation in AML
1:35
Maximizing the graft-versus-leukemia effect after allogeneic transplantation in AML
Charles Craddock • 19 Sep 2026
Optimizing allogeneic transplantation through prospective randomized trials in AML
3:08
Optimizing allogeneic transplantation through prospective randomized trials in AML
Charles Craddock • 19 Sep 2026

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals